Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15278 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Jessica Hedvat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, NewYork-Presbyterian Hospital, New York City, New York, USA. Hauptthemen laut MEDLINE: Tacrolimus, Organ Transplantation, Nitriles, Pyridines. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, NewYork-Presbyterian Hospital, New York City, New York, USA.
- Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York City, New York, USA.
ORCID-Profile: Jessica Hedvat, Nicholas W Lange, Marcus R Pereira, David M Salerno
Zitieren
APA
Hedvat, J., Lange, N. W., Scheffert, J. L., Pereira, M. R., & Salerno, D. M. (2024). Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15278
Vancouver
Hedvat J, Lange NW, Scheffert JL, Pereira MR, Salerno DM. Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients. Clinical Transplantation. 2024. doi:10.1111/ctr.15278
BibTeX
@article{Hedvat2024,
author = {Hedvat, Jessica and Lange, Nicholas W and Scheffert, Jenna L and Pereira, Marcus R and Salerno, David M},
title = {Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15278}
}
EUVIMED